Skip to main content

Advertisement

SpringerLink
Log in

Dual drug delivery of curcumin and niclosamide using PLGA nanoparticles for improved therapeutic effect on breast cancer cells

  • ORIGINAL PAPER
  • Published:
Journal of Polymer Research Aims and scope Submit manuscript

Abstract

A number of potent chemopreventives like curcumin and niclosamide have shown promising activities in cancer, although having the drawback of poor bioavailability. To improve the utility of these drugs in cancer therapy, we have encapsulated curcumin and niclosamide in poly(lactic-co-glycolide) (PLGA) nanoparticles, in the presence of poly(vinyl alcohol), using the nanoprecipitation method. We successfully synthesised spherical PLGA nanoparticles, either with each of the single drug individually or with both drugs together, for dual drug loaded samples. FTIR spectroscopy confirmed the successful loading of curcumin and niclosamide in PLGA nanoparticles. The encapsulation efficiency was 48.15% and 70.27% for curcumin and niclosamide, respectively, when loaded individually; which increased to 58.09% for curcumin and 85.36% for niclosamide, with simultaneous dual drug encapsulation. In vitro drug release showed that, as required, a much higher amount of drug released at the acidic pH 6.0 of cancer cells (86.01%, 95.04%, for curcumin and niclosamide, respectively), compared to normal, healthy cell’s pH of 7.4 (25.70% and 60.92% for these two same drugs). MTT assay revealed that dual-drug loaded PLGA nanoparticles exhibited a higher anticancer effect, compared to a bare mixture of two drugs in DMSO (having no PLGA). Therefore, PLGA nanoparticles can be used as an effective carrier to deliver the two hydrophobic drugs to MDA-MB-231 breast cancer cells, for a superior anticancer effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30

    Article  PubMed  Google Scholar 

  2. Yallapu MM, Gupta BK, Jaggi M, Chauhan SC (2010) Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci 351:19–29

    Article  CAS  PubMed  Google Scholar 

  3. Pari L, Tewas D, Eckel J (2008) Role of curcumin in health and disease. Arch Physiol Biochem 114:127–149

    Article  CAS  PubMed  Google Scholar 

  4. Bansal SS, Goel M, Aqil F, Vadhanam MV, Gupta RC (2011) Advanced drug-delivery systems of curcumin for cancer chemoprevention. Cancer Prev Res 4:1158–1171

    Article  CAS  Google Scholar 

  5. Lu W, Lin C, Roberts MJ et al (2011) Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway. PLoS One 6:e29290

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Liao Z, Nan G, Yan Z, Zeng L, Deng Y, Ye J, Zhang Z, Qiao M, Li R, Denduluri S, Wang J, Wei Q, Geng N, Zhao L, Lu S, Wang X, Zhou G, Luu HH, Haydon RC, He TC, Wang Z (2015) The anthelmintic drug niclosamide inhibits the proliferative activity of human osteosarcoma cells by targeting multiple signal pathways. Curr Cancer Drug Targets 15:726–738

    Article  CAS  PubMed  Google Scholar 

  7. Shureiqi I, Reddy P, Brenner DE (2000) Chemoprevention: general perspective. Crit Rev Oncol Hematol 33:157–167

    Article  CAS  PubMed  Google Scholar 

  8. Park W, Amin ARMR, Chen ZG, Shin DM (2013) New perspectives of curcumin in cancer prevention. Cancer Prev Res 6:387–400

    Article  CAS  Google Scholar 

  9. Khan N, Shreaz S, Bhatia R, Ahmad SI, Muralidhar S, Manzoor N, Khan LA (2012) Anticandidal activity of curcumin and methyl cinnamaldehyde. Fitoterapia 83:434–440

    Article  CAS  PubMed  Google Scholar 

  10. Ren X, Duan L, He Q, Zhang Z, Zhou Y, Wu D, Pan J, Pei D, Ding K (2010) Identification of niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway. ACS Med Chem Lett 1:454–459

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Chen H, Yang Z, Ding C, Chu L, Zhang Y, Terry K, Liu H, Shen Q, Zhou J (2013) Discovery of O-alkylamino-tethered niclosamide derivatives as potent and orally bioavailable anticancer agents. ACS Med Chem Lett 4:180–185

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–818

    Article  CAS  PubMed  Google Scholar 

  13. Sharma RA, Steward WP, Gescher AJ (2007) Pharmacokinetics and pharmacodynamics of curcumin. The molecular targets and therapeutic uses of curcumin in health and disease. Springer, In, pp 453–470

    Google Scholar 

  14. Elkihel L, Loiseau PM, Bourass J, Gayral P, Letourneux Y (1994) Synthesis and orally macrofilaricidal evaluation of niclosamide lymphotropic prodrugs. Arzneimittelforschung 44:1259–1264

    CAS  PubMed  Google Scholar 

  15. Navab M, Ruchala P, Waring AJ, Lehrer RI, Hama S, Hough G, Palgunachari MN, Anantharamaiah GM, Fogelman AM (2009) A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids. J Lipid Res 50:1538–1547

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Kunwar A, Barik A, Pandey R, Priyadarsini KI (2006) Transport of liposomal and albumin loaded curcumin to living cells: an absorption and fluorescence spectroscopic study. Biochim Biophys Acta - Gen Subj 1760:1513–1520

    Article  CAS  Google Scholar 

  17. Hardiansyah A, Destyorini F, Irmawati Y et al (2019) Characterizations of doxorubicin-loaded PEGylated magnetic liposomes for cancer cells therapy. J Polym Res 26:282

    Article  CAS  Google Scholar 

  18. Uekama K, Hirayama F, Irie T (1998) Cyclodextrin drug carrier systems. Chem Rev 98:2045–2076

    Article  CAS  PubMed  Google Scholar 

  19. Kaolaor A, Phunpee S, Ruktanonchai UR, Suwantong O (2019) Effects of β-cyclodextrin complexation of curcumin and quaternization of chitosan on the properties of the blend films for use as wound dressings. J Polym Res 26:43

    Article  CAS  Google Scholar 

  20. Kakkar V, Singh S, Singla D et al (2010) Pharmacokinetic applicability of a validated liquid chromatography tandem mass spectroscopy method for orally administered curcumin loaded solid lipid nanoparticles to rats. J Chromatogr B 878:3427–3431

    Article  CAS  Google Scholar 

  21. Tiyaboonchai W, Tungpradit W, Plianbangchang P (2007) Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm 337:299–306

    Article  CAS  PubMed  Google Scholar 

  22. Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37:223–230

    Article  CAS  PubMed  Google Scholar 

  23. Tsai YM, Chien CF, Lin LC, Tsai TH (2011) Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int J Pharm 416:331–338

    Article  CAS  PubMed  Google Scholar 

  24. Azizi M, Farahmandghavi F, Joghataei M et al (2013) Fabrication of protein-loaded PLGA nanoparticles: effect of selected formulation variables on particle size and release profile. J Polym Res 20:110

    Article  CAS  Google Scholar 

  25. Wong M-Y, Chiu GNC (2011) Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model. Nanomedicine Nanotechnology, Biol Med 7:834–840

    Article  CAS  Google Scholar 

  26. Ahlin P, Jerenec N, Kristl J (2001) Influence of formulation variables on the size of PLGA and PLA nanoparticles prepared by an emulsification-diffusion technique. Sci Pharm 69:S167–S168

    Article  Google Scholar 

  27. Eley JG, Pujari VD, McLane J (2004) Poly (lactide-co-glycolide) nanoparticles containing coumarin-6 for suppository delivery: in vitro release profile and in vivo tissue distribution. Drug Deliv 11:255–261

    Article  CAS  PubMed  Google Scholar 

  28. Win KY, Feng S-S (2005) Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26:2713–2722

    Article  CAS  PubMed  Google Scholar 

  29. Panyam J, Zhou W-Z, Prabha S, Sahoo SK, Labhasetwar V (2002) Rapid endo-lysosomal escape of poly (DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 16:1217–1226

    Article  CAS  PubMed  Google Scholar 

  30. Horisawa E, Hirota T, Kawazoe S, Yamada J, Yamamoto H, Takeuchi H, Kawashima Y (2002) Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit. Pharm Res 19:403–410

    Article  CAS  PubMed  Google Scholar 

  31. Cegnar M, Kos J, Kristl J (2004) Cystatin incorporated in poly (lactide-co-glycolide) nanoparticles: development and fundamental studies on preservation of its activity. Eur J Pharm Sci 22:357–364

    Article  CAS  PubMed  Google Scholar 

  32. Vyas SP, Khar RK (2004) Targeted & controlled drug delivery: novel carrier systems. CBS publishers & distributors

  33. Makadia HK, Siegel SJ (2011) Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 3:1377–1397

    Article  CAS  Google Scholar 

  34. Acharya S, Sahoo SK (2011) PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 63:170–183

    Article  CAS  PubMed  Google Scholar 

  35. Aggarwal S, Gupta S, Pabla D, Murthy RSR (2013) Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer. Cancer Nanotechnol 4:145–157

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Zhang M, Tang Y, Zhu Z, Zhao H, Yao J, Sun D (2018) Paclitaxel and etoposide-loaded poly (lactic-co-glycolic acid) microspheres fabricated by coaxial electrospraying for dual drug delivery. J Biomater Sci Polym Ed 29:1949–1963

    Article  CAS  PubMed  Google Scholar 

  37. Duan J, Mansour HM, Zhang Y, Deng X, Chen Y, Wang J, Pan Y, Zhao J (2012) Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly (butyl cyanoacrylate) nanoparticles. Int J Pharm 426:193–201

    Article  CAS  PubMed  Google Scholar 

  38. Li H, Yu H, Zhu C et al (2016) Cisplatin and doxorubicin dual-loaded mesoporous silica nanoparticles for controlled drug delivery. RSC Adv 6:94160–94169

    Article  CAS  Google Scholar 

  39. Gan Q, Zhu J, Yuan Y, Liu H, Qian J, Li Y, Liu C (2015) A dual-delivery system of pH-responsive chitosan-functionalized mesoporous silica nanoparticles bearing BMP-2 and dexamethasone for enhanced bone regeneration. J Mater Chem B 3:2056–2066

    Article  CAS  PubMed  Google Scholar 

  40. Narayanan S, Pavithran M, Viswanath A et al (2014) Sequentially releasing dual-drug-loaded PLGA–casein core/shell nanomedicine: design, synthesis, biocompatibility and pharmacokinetics. Acta Biomater 10:2112–2124

    Article  CAS  PubMed  Google Scholar 

  41. Singh PK, Wani K, Kaul-Ghanekar R et al (2014) From micron to nano-curcumin by sophorolipid co-processing: highly enhanced bioavailability, fluorescence, and anti-cancer efficacy. RSC Adv 4:60334–60341

    Article  CAS  Google Scholar 

  42. Narayanan K, Subrahmanyam VM, Venkata Rao J (2014) A fractional factorial design to study the effect of process variables on the preparation of hyaluronidase loaded PLGA nanoparticles. Enzyme Res 2014

  43. Singh G, Kaur T, Kaur R, Kaur A (2014) Recent biomedical applications and patents on biodegradable polymer-PLGA. Int J Pharmacol Pharm Sci 1:30–42

    CAS  Google Scholar 

  44. Tan HY, Widjaja E, Boey F, Loo SCJ (2009) Spectroscopy techniques for analyzing the hydrolysis of PLGA and PLLA. J Biomed Mater Res Part B Appl Biomater 91:433–440

    Article  CAS  Google Scholar 

  45. Sadeghi-Avalshahr A, Nokhasteh S, Molavi AM, Khorsand-Ghayeni M, Mahdavi-Shahri M (2017) Synthesis and characterization of collagen/PLGA biodegradable skin scaffold fibers. Regen Biomater 4:309–314

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Ahmadi E, Zarghami N, Jafarabadi MA et al (2019) Enhanced anticancer potency by combination chemotherapy of HT-29 cells with biodegradable, pH-sensitive nanoparticles for co-delivery of hydroxytyrosol and doxorubicin. J Drug Deliv Sci Technol 51:721–735

    Article  CAS  Google Scholar 

  47. Xie X, Tao Q, Zou Y, Zhang F, Guo M, Wang Y, Wang H, Zhou Q, Yu S (2011) PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. J Agric Food Chem 59:9280–9289

    Article  CAS  PubMed  Google Scholar 

  48. Dubey RD, Saneja A, Qayum A et al (2016) PLGA nanoparticles augmented the anticancer potential of pentacyclic triterpenediol in vivo in mice. RSC Adv 6:74586–74597

    Article  CAS  Google Scholar 

  49. Van Tonder EC, Mahlatji MD, Malan SF et al (2004) Preparation and physicochemical characterization of 5 niclosamide solvates and 1 hemisolvate. AAPS PharmSciTech 5:86

    Article  PubMed Central  Google Scholar 

  50. Mukerjee A, Vishwanatha JK (2009) Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res 29:3867–3875

    CAS  PubMed  Google Scholar 

  51. Verderio P, Bonetti P, Colombo M et al (2013) Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells. Biomacromolecules 14:672–682

    Article  CAS  PubMed  Google Scholar 

  52. Jain NK, Prabhuraj RS, Bavya MC et al (2019) Niclosamide encapsulated polymeric nanocarriers for targeted cancer therapy. RSC Adv 9:26572–26581

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We acknowledge the Sophisticated Analytical Instrumental Facility (SAIF) and Industrial Research Consultancy Centre (IRCC), Indian Institute of Technology, Bombay for providing the necessary instrumental facility for successful completion of the work.

Author information

Authors and Affiliations

  1. Centre for Research in Nanotechnology and Science, Indian Institute of Technology Bombay, Powai, Mumbai, 400076, India

    Prabhuraj R.S.

  2. Department of Chemical Engineering, Indian Institute of Technology Bombay, Powai, Mumbai, 400076, India

    Kartik Bomb & Rajdip Bandyopadhyaya

  3. Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, 400076, India

    Rohit Srivastava

Authors
  1. Prabhuraj R.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kartik Bomb
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rohit Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rajdip Bandyopadhyaya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rajdip Bandyopadhyaya.

Ethics declarations

Conflict of interest

The authors declare no completing financial interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 111 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

R.S., P., Bomb, K., Srivastava, R. et al. Dual drug delivery of curcumin and niclosamide using PLGA nanoparticles for improved therapeutic effect on breast cancer cells. J Polym Res 27, 133 (2020). https://doi.org/10.1007/s10965-020-02092-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10965-020-02092-7

Keywords

Search

Navigation